E J Hornby

449 total citations
13 papers, 387 citations indexed

About

E J Hornby is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Pharmacology. According to data from OpenAlex, E J Hornby has authored 13 papers receiving a total of 387 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Cardiology and Cardiovascular Medicine, 4 papers in Molecular Biology and 4 papers in Pharmacology. Recurrent topics in E J Hornby's work include Antiplatelet Therapy and Cardiovascular Diseases (7 papers), Platelet Disorders and Treatments (4 papers) and Inflammatory mediators and NSAID effects (3 papers). E J Hornby is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (7 papers), Platelet Disorders and Treatments (4 papers) and Inflammatory mediators and NSAID effects (3 papers). E J Hornby collaborates with scholars based in United Kingdom, Italy and United States. E J Hornby's co-authors include I.F. Skidmore, Jill Coates, F. Ellis, B. A. J. Evans, Alan Wheeldon, Peter Strong, I. Kennedy, C.J. Vardey, Patrick McCabe and Penelope J. Hallett and has published in prestigious journals such as Circulation, FEBS Letters and British Journal of Pharmacology.

In The Last Decade

E J Hornby

13 papers receiving 369 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
E J Hornby United Kingdom	8	129	123	117	82	66	13	387
Emese Tóth-Zsámboki Hungary	12	255 2.0×	118 1.0×	35 0.3×	213 2.6×	34 0.5×	21	586
Huzoor‐Akbar United States	13	85 0.7×	153 1.2×	92 0.8×	8 0.1×	62 0.9×	23	357
Barry Cooper United States	13	136 1.1×	259 2.1×	182 1.6×	8 0.1×	137 2.1×	18	697
Pamela Tranter United Kingdom	7	46 0.4×	171 1.4×	13 0.1×	35 0.4×	50 0.8×	12	315
Martina Delbeck Germany	10	166 1.3×	239 1.9×	49 0.4×	16 0.2×	50 0.8×	14	651
Remo D. Spescha Switzerland	9	63 0.5×	126 1.0×	30 0.3×	20 0.2×	132 2.0×	11	404
Tamio Hagiwara Japan	13	60 0.5×	122 1.0×	80 0.7×	47 0.6×	91 1.4×	22	432
Rudolf Locher Switzerland	13	69 0.5×	174 1.4×	21 0.2×	6 0.1×	97 1.5×	21	514
Hiroo Itoh Japan	10	181 1.4×	179 1.5×	108 0.9×	6 0.1×	78 1.2×	14	492
Silvia Pomposiello United States	12	132 1.0×	200 1.6×	47 0.4×	12 0.1×	142 2.2×	18	575

Countries citing papers authored by E J Hornby

Since Specialization

Citations

This map shows the geographic impact of E J Hornby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E J Hornby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E J Hornby more than expected).

Fields of papers citing papers by E J Hornby

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E J Hornby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E J Hornby. The network helps show where E J Hornby may publish in the future.

Co-authorship network of co-authors of E J Hornby

This figure shows the co-authorship network connecting the top 25 collaborators of E J Hornby. A scholar is included among the top collaborators of E J Hornby based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E J Hornby. E J Hornby is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Hornby, E J, Susan H. Brown, Michael M. Hann, et al.. (1994). Inhibition of human platelet aggregation by GR91669, a prototype fibrinogen receptor antagonist. Thrombosis Research. 75(3). 269–284. 5 indexed citations

Cirillo, R, Gjumrakch Aliev, E J Hornby, & Marco Prosdocimi. (1994). Endothelium as a therapeutical target in peripheral occlusive arterial diseases: consideration for pharmacological interventions. Pharmacological Research. 29(4). 293–311. 13 indexed citations

Hornby, E J, et al.. (1993). Improved potency and specificity of Arg-Gly-Asp (RGD) containing peptides as fibrinogen receptor blocking drugs. Thrombosis Research. 72(3). 231–245. 11 indexed citations

Coates, Jill, F. Ellis, B. A. J. Evans, et al.. (1993). Functional characterization of three adenosine receptor types. British Journal of Pharmacology. 109(3). 693–698. 115 indexed citations

Hornby, E J, et al.. (1991). Activation of human platelets by exposure to a monoclonal antibody, PM6/248, to glycoprotein IIb‐IIIa. British Journal of Haematology. 79(2). 277–285. 14 indexed citations

Hornby, E J, et al.. (1989). The Inhibitory Effect of GR32191, a Thromboxane Receptor Blocking Drug, on Human Platelet Aggregation, Adhesion and Secretion. Thrombosis and Haemostasis. 61(3). 429–436. 32 indexed citations

McCabe, Patrick, et al.. (1987). INHIBITION OF GUINEA-PIG PLATELET FUNCTION IN VIVO AND EX VIVO USING THE THROMBOXANE A2 ANTAGONISTS, AH23848 AND GR32191. Thrombosis and Haemostasis. 3 indexed citations

Lumley, P. J., E. W. COLLINGTON, Penelope J. Hallett, et al.. (1987). THE EFFECTS OF GR32191, A NEW THROMBOXANE RECEPTOR BLOCKING DRUG,ON PLATELETS AND VASCULAR SMOOTH MUSCLE IN VITRO. Thrombosis and Haemostasis. 5 indexed citations

Authi, Kalwant S., et al.. (1987). Inositol 1,4,5‐trisphosphate (IB₃) induced rapid formation of thromboxane B₂ in saponin‐permeabilised human platelets: mechanism of IP₃ action. FEBS Letters. 213(1). 95–101. 22 indexed citations

10.

Hornby, E J, et al.. (1987). INHIBITION OF HUMAN PLATELET AGGREGATION BY THE THROMBOXANE MIMETIC, U46619. Thrombosis and Haemostasis. 1 indexed citations

11.

Brittain, R T, Robert A. Coleman, E. W. COLLINGTON, et al.. (1985). AH23848: a thromboxane receptor-blocking drug that can clarify the pathophysiologic role of thromboxane A2.. Circulation. 72(6). 1208–1218. 70 indexed citations

12.

Hornby, E J, et al.. (1983). 1-O-Hexadecyl-2-Acetyl-SN-3-Glycerophosphoryl- choline (PAF): Some Effects on the Aggregation of Human Platelets by Thrombin or Collagen. Thrombosis and Haemostasis. 50(2). 586–587. 6 indexed citations

13.

Hornby, E J & I.F. Skidmore. (1982). Evidence that prostaglandin endoperoxides can induce platelet aggregation in the absence of thromboxane A2 production. Biochemical Pharmacology. 31(6). 1158–1160. 90 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact